Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an update following a recent
AMC Entertainment (AMC)
Orbital Energy Group (OEG)
BriaCell Therapeutics (BCTX)
BlackBerry (BB)
NIO Inc. (NIO)
Washington Prime Group (WPG)
Vertex Energy (VTNR)
Zoom Video Communications (ZM)
Stealth